GlassScriptPhysician profile
Michael J Schweid
NPI 1457418923
$1,083.69
in general payments reported to CMS, 2019-2025
18 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $332 · 2023: $251 · 2024: $156 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $183.63 | 2021-2025 | Aquamantys(Tm) |
| Zimvie INC. | $166.52 | 2023 | |
| Stryker Corporation | $142.19 | 2022 | |
| Bioventus LLC | $105.59 | 2021 | |
| Boston Scientific Corporation | $93.98 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $57.36 | 2021-2023 | Symphony |
| Globus Medical, INC. | $56.22 | 2025 | Allocate, Vyrsa V1 |
| Kowa Pharmaceuticals America, INC. | $34.94 | 2023 | Seglentis |
| Arteriocyte Medical Systems, INC. | $33.47 | 2021-2024 | Magellan |
| Vertex Pharmaceuticals Incorporated | $33.01 | 2025 | |
| Edwards Lifesciences Corporation | $31.44 | 2022 | |
| Si-Bone, INC. | $24.61 | 2024 | |
| Aroa Biosurgery Incorporated | $23.82 | 2024 | |
| Nevro Corp. | $22.01 | 2024 | Senza |
| Aesculap, INC. | $21.82 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.79 | 2025 | |
| Amgen INC. | $18.29 | 2024 | Prolia, Evenity |
| Theragen, INC. | $16.00 | 2024 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schweid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.